Hostname: page-component-848d4c4894-cjp7w Total loading time: 0 Render date: 2024-07-01T01:44:23.287Z Has data issue: false hasContentIssue false
  • English
  • Français

Spectrum of nasal disease in an asthma clinic: when is an ENT opinion indicated?

Published online by Cambridge University Press:  02 September 2008

A E Stanton ,
G W McGarry ,
R Carter  and
C E Bucknall
A E Stanton*
Affiliation:
Department of Respiratory Medicine, Glasgow Royal Infirmary, Scotland, UK
G W McGarry
Affiliation:
Department of Otorhinolaryngology, Glasgow Royal Infirmary, Scotland, UK
R Carter
Affiliation:
Department of Respiratory Medicine, Glasgow Royal Infirmary, Scotland, UK
C E Bucknall
Affiliation:
Department of Respiratory Medicine, Glasgow Royal Infirmary, Scotland, UK
*
Address for correspondence: Dr Andrew E Stanton, Osler Chest Unit, Churchill Hospital, Headington, Oxford OX3 7LJ, UK. Fax: 01865 225 221 E-mail: andrewestanton@hotmail.com
Get access Rights & Permissions [Opens in a new window]

Abstract

Aims:

To characterise the spectrum of nasal symptomatology and nasendoscopic abnormalities seen in patients attending an asthma clinic, and to relate these symptoms to the likelihood of finding nasendoscopic abnormalities which merit treatment.

Methods:

Forty-three patients attending a problem asthma clinic were enrolled in an observational study. Cardinal nasal symptoms – obstruction, congestion, hyposmia, rhinorrhoea, sneezing, epistaxis or other symptoms – were graded as none (zero), mild (one), moderate (two) or severe (three), giving a maximum nasal symptom score of 21. Asthma symptoms and lung function were measured. Nasendoscopy was then performed.

Results:

Obstruction was the most common cardinal nasal symptom (seen in 15 patients), the median nasal symptom score was 5.3 (range zero to 14) and only three patients had no nasal symptoms. There was no correlation between nasal symptom score and severity of asthma symptoms or forced expiratory volume in one second. Twenty-two patients had a normal appearance on ENT examination (median nasal symptom score four). The nasendoscopic abnormalities seen comprised polyps (n = 8; median nasal symptom score five), deviated nasal septum (n = 7; median nasal symptom score four), oedematous mucosa (n = 4; median nasal symptom score seven) and other abnormalities (n = 2). Individual nasal symptoms were poor predictors of individual nasal pathologies, with hyposmia the best individual predictor of any abnormality (positive predictive value 80 per cent). The presence of a combination of symptoms increased the likelihood of any nasendoscopic abnormality, with obstruction, rhinorrhoea and hyposmia together having a positive predictive value of 100 per cent.

Conclusions:

Nasal symptoms are much more frequent than structural abnormalities in patients attending a problem asthma clinic. The threshold for ENT referral should be lower when the patient complains of a symptom complex including hyposmia. Furthermore, concurrent hyposmia, obstruction and rhinorrhoea should be seen as an indication for ENT referral.

Keywords

AsthmaSigns and SymptomsNasal Polyps
Type
Main Articles
Information
The Journal of Laryngology & Otology , Volume 123 , Issue 6 , June 2009 , pp. 613 - 618
Copyright
Copyright © JLO (1984) Limited 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Presented in abstract form to the European Respiratory Society meeting, 6 September 2004, Glasgow, Scotland, UK.

Previously published as ‘The spectrum of upper airway problems in a problem asthma clinic – the role of the nose.’ Eur Resp J 2004;24(suppl 48):P1710

References

1 Simons, FE. Allergic rhinobronchitis: the asthma-allergic rhinitis link. J Allergy Clin Immunol 1999;104:534–40CrossRefGoogle ScholarPubMed
2 Bousquet, JM, van Cauwenberge, PMP, Khaltaev, NM. In collaboration with the World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108(Suppl 5, part 2):147s–334sCrossRefGoogle Scholar
3 Larsen, K. The clinical relationship of nasal polyps to asthma. Allergy Asthma Proc 1996;17:243–9Google Scholar
4 Settipane, GA. Epidemiology of nasal polyps. Allergy Asthma Proc 1996;17:231–6CrossRefGoogle ScholarPubMed
5 Pedersen, PA, Weeke, ER. Asthma and allergic rhinitis in the same patients. Allergy 1983;38:25–9CrossRefGoogle ScholarPubMed
6 Blair, H. Natural history of childhood asthma. 20-year follow-up. Arch Dis Child 1977;52:613–19CrossRefGoogle ScholarPubMed
7 Stanton, AE, Sellars, C, Dunnet, C, MacKenzie, K, Carter, R, Bucknall, CE. Perceived vocal morbidity in a problem asthma clinic. Eur Respir J 2004;24(suppl 48):A2887Google Scholar
8 Stanton, AE, Johnson, MK, MacKenzie, K, Carter, R, Bucknall, CE. Physiological evaluation of the upper airway in a problem asthma clinic. Eur Respir J 2004;24(suppl 48):1712Google Scholar
9 Stanton, AE, MacKenzie, K, Carter, R, Bucknall, CE. The spectrum of upper airway problems in a problem asthma clinic – the role of the larynx. Eur Respir J 2004;24(suppl 48):P1711Google Scholar
10 Pearson, MG, Bucknall, CE. Measuring Clinical Outcome in Asthma; a Patient Focussed Approach. London: Royal College of Physicians, 1999Google Scholar
11 Guidelines for the measurement of respiratory function. Recommendations of the British Thoracic Society and the Association of Respiratory Technicians and Physiologists. Respir Med 1994;88:165–94Google Scholar
12 Quanjer, PH, Tammeling, GJ, Cotes, JE, Pedersen, OF, Peslin, R, Yernault, JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993;16:5–40CrossRefGoogle ScholarPubMed
13 Altman, DG. Practical Statistics for Medical Research, 1st edn. London: Chapman and Hall, 1991Google Scholar
14 British Thoracic Society, Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. Thorax 2003;58(suppl 1):i1–94Google Scholar
15 Hedman, J, Kaprio, J, Poussa, T, Nieminen, MM. Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. Int J Epidemiol 1999;28:717–22CrossRefGoogle ScholarPubMed
16 Montnemery, P, Svensson, C, Adelroth, E, Lofdahl, CG, Andersson, M, Greiff, L et al. Prevalence of nasal symptoms and their relation to self-reported asthma and chronic bronchitis/emphysema. Eur Respir J 2001;17:596–603CrossRefGoogle ScholarPubMed